APOA1 and metabolic dysfunction-associated steatohepatitis: Interestingly, there is a naturally occurring variant of APOA-I, namely APOA-IMilano, which has stronger antiatherogenic capacity [256]; its use in an APOA-I knockout mouse was able to completely revert the NASH phenotype [257].